Kestra Medical Technologies Inc(KMTS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KMTS Kestra Medical Technologies Inc

Trading 01-23 11:42:38 EST

24.81

+0.10

+0.40%

High24.98	Low23.95	Vol36.07K
Open24.68	D1 Closing24.71	Amplitude4.18%
Mkt Cap1.45B	Tradable Cap762.59M	Total Shares58.35M
T/O889.98K	T/O Rate0.12%	Tradable Shares30.74M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KMTS","market":"US","secType":"STK","nameCN":"Kestra Medical Technologies Inc","latestPrice":24.81,"timestamp":1769186536754,"preClose":24.71,"halted":0,"volume":36070,"delay":0,"changeRate":0.004046944556859485,"floatShares":30737300,"shares":58349053,"eps":-2.698,"marketStatus":"Trading","change":0.1,"latestTime":"01-23 11:42:38 EST","open":24.68,"high":24.98,"low":23.9481,"amount":889984.6873999999,"amplitude":0.04176,"askPrice":24.9,"askSize":33,"bidPrice":24.71,"bidSize":103,"shortable":3,"etf":0,"ttmEps":-2.698,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1769202000000},"marketStatusCode":2,"adr":0,"listingDate":1741237200000,"exchange":"NASDAQ","adjPreClose":24.71,"postHourTrading":{"tag":"盘后","latestPrice":24.71,"preClose":24.71,"latestTime":"18:14 EST","volume":3270,"amount":80817.7,"timestamp":1769123641450,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.481941},"requestUrl":"/m/hq/s/KMTS/wiki","defaultTab":"wiki","newsList":[{"id":"2604272194","title":"Kestra Medical Technologies Ltd. Officer Brian Daniel Webster Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2604272194","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604272194?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:04","pubTimestamp":1768907076,"startTime":"0","endTime":"0","summary":"Brian Daniel Webster, Director and Officer of Kestra Medical Technologies Ltd., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL31d7Bw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kestra Medical Technologies Ltd. Officer Brian Daniel Webster Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2603688491","title":"Kestra Medical Technologies Invests $5 Million in Biobeat Series B Round","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688491","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603688491?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:00","pubTimestamp":1768302039,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Ltd. has entered into a strategic collaboration with Biobeat Technologies Ltd., which includes a $5 million equity investment in Biobeat's recently announced Series B financing. As part of the agreement, Kestra has secured an exclusive license and co-development arrangement with Biobeat to enhance diagnostic insights for patients prescribed the ASSURE Wearable Cardioverter Defibrillator.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via GlobeNewswire  on January 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDLbBH6CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014013.SGD","LU2095319765.USD","SG9999014039.USD","LU2210150020.SGD","KMTS","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","SG9999014005.SGD","BK4588","LU2210149790.SGD","BK4082","LU0314104364.USD","BK4585","SG9999014021.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2603688479","title":"Kestra Medical Technologies Ltd - Agreement Includes Exclusive License, $5 Mln Equity Investment in Biobeat's Series B","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688479","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603688479?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:00","pubTimestamp":1768302028,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE0JN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2603688231","title":"Kestra Medical Technologies Announces Strategic Collaboration With Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688231","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603688231?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:00","pubTimestamp":1768302028,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2602043322","title":"Kestra Medical price target raised to $27 from $25 at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2602043322","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602043322?lang=en_us&edition=fundamental","pubTime":"2026-01-09 18:56","pubTimestamp":1767956170,"startTime":"0","endTime":"0","summary":"Goldman Sachs raised the firm’s price target on Kestra Medical (KMTS) to $27 from $25 and keeps a Neutral rating on the shares. After a year when f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kestra-medical-price-target-raised-to-27-from-25-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kestra-medical-price-target-raised-to-27-from-25-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443895.HKD","LU1791807156.HKD","IE0004091025.USD","BK4504","IE00B19Z3581.USD","LU0096364046.USD","LU1868837136.USD","LU2237443465.HKD","LU1894683264.USD","LU0345770308.USD","BK4585","LU1868837300.USD","LU2471134523.USD","LU1868836591.USD","LU1868836757.USD","LU2237443382.USD","BK4588","LU0061475181.USD","LU1668664300.SGD","LU2237443622.USD","LU1868836914.USD","LU2750360641.GBP","BK4552","IE00BSNM7G36.USD","LU2471134796.USD","LU0742534661.SGD","IE00BFXG1179.USD","IE00B19Z3B42.SGD","LU2750360997.AUD","IE0004086264.USD","LU0345770993.USD","LU2237443549.SGD","BK4082","BK4127","LU0251131958.USD","LU2237443978.SGD","KMTS","LU1804176565.USD","BK4516","BK4550","LU2237438978.USD","LU0251142724.SGD","IE0034235188.USD","BK4533","LU0048573561.USD","LU0106831901.USD","LU2265009873.SGD","LU2471134952.CNY","IE0002270589.USD"],"gpt_icon":0},{"id":"2600701367","title":"Kestra Medical Technologies Officer Brian Daniel Webster Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2600701367","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600701367?lang=en_us&edition=fundamental","pubTime":"2026-01-01 05:15","pubTimestamp":1767215713,"startTime":"0","endTime":"0","summary":"Brian Daniel Webster, Director and Officer of Kestra Medical Technologies Ltd., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kestra Medical Technologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 31, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL9R3CkC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kestra Medical Technologies Officer Brian Daniel Webster Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2592488969","title":"Is Kestra Medical Technologies (KMTS) Overvalued After Its Recent Share Price Climb?","url":"https://stock-news.laohu8.com/highlight/detail?id=2592488969","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592488969?lang=en_us&edition=fundamental","pubTime":"2025-12-18 01:19","pubTimestamp":1765991975,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies (KMTS) has been quietly grinding higher, with the stock up around 2% on the day, nearly 9% over the past week, and roughly 24% year to date.\nSee our latest analysis for Kestra Medical Technologies.\nThat kind of steady climb in the share price, capped by a 1 day share price return of just under 2 percent, suggests momentum is building as investors warm to Kestra Medical Technologies growth story and reassess its risk profile.\nIf this move in Kestra Medical...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/is-kestra-medical-technologies-kmts-overvalued-after-its-rec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/is-kestra-medical-technologies-kmts-overvalued-after-its-rec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2590502044","title":"Kestra Medical Techs Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2590502044","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590502044?lang=en_us&edition=fundamental","pubTime":"2025-12-12 22:52","pubTimestamp":1765551120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KMTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 12, 2025 09:52 ET (14:52 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"1122461542","title":"Stock Track | Kestra Medical Technologies Plunges 12.47% After-Hours on Q2 EPS Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=1122461542","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122461542?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:56","pubTimestamp":1765490185,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Inc (KMTS) shares plummeted 12.47% in after-hours trading following the release of its Q2 FY26 financial results. The company reported a loss of $0.64 per share, missing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KMTS"],"gpt_icon":0},{"id":"2590549223","title":"Cardiac monitor maker Kestra's Q2 revenue beats estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2590549223","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590549223?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:11","pubTimestamp":1765487480,"startTime":"0","endTime":"0","summary":"Cardiac monitor maker Kestra's Q2 revenue beats estimatesOverviewWearable medical device firm's fiscal Q2 revenue rose 53%, beating analyst expectationsAdjusted EBITDA loss for fiscal Q2 beat analyst ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nL1N3XH10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2590549194","title":"Earnings Flash (KMTS) Kestra Medical Technologies Posts Q2 Loss $0.64, vs. FactSet Est of $0.59 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2590549194","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590549194?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:05","pubTimestamp":1765487155,"startTime":"0","endTime":"0","summary":"Earnings Flash (KMTS) Kestra Medical Technologies Posts Q2 Loss $0.64, vs. FactSet Est of $0.59 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2590491975","title":"GUIDANCE: (KMTS) Kestra Medical Technologies Now Expects Full Year 2026 Revenue $91M, vs. FactSet Est of $88.1M","url":"https://stock-news.laohu8.com/highlight/detail?id=2590491975","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590491975?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:05","pubTimestamp":1765487137,"startTime":"0","endTime":"0","summary":"GUIDANCE: (KMTS) Kestra Medical Technologies Now Expects Full Year 2026 Revenue $91M, vs. FactSet Est of $88.1M","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2590549992","title":"Kestra Medical Techs Q2 EPS $(0.64) Misses $(0.59) Estimate, Sales $22.565M Beat $20.704M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2590549992","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590549992?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:02","pubTimestamp":1765486933,"startTime":"0","endTime":"0","summary":"Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.59) by 8.11 percent.  The company reported quarterly sales of $22.565 million which","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49348015/kestra-medical-techs-q2-eps-0-64-misses-0-59-estimate-sales-22-565m-beat-20-704m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kestra Medical Techs Q2 EPS $(0.64) Misses $(0.59) Estimate, Sales $22.565M Beat $20.704M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2590499835","title":"BRIEF-Kestra Medical Technologies Inc Q2 EPS USD -0.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2590499835","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590499835?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:01","pubTimestamp":1765486905,"startTime":"0","endTime":"0","summary":"Dec 11  - Kestra Medical Technologies Inc Q2 revenue USD 22.565 million vs. IBES estimate USD 20.7 million.Q2 adjusted EBITDA USD -19.682 million vs. IBES estimate USD -20.6 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nPLX2A4C6E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2590654967","title":"Kestra Medical Technologies Inc Q2 Revenue USD 22.565 Million VS. Ibes Estimate USD 20.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2590654967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590654967?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:01","pubTimestamp":1765486860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nPLX2A4C6E:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","KMTS"],"gpt_icon":0},{"id":"2590549606","title":"Kestra Medical Technologies Inc Outlook FY Revenue Growth 52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590549606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590549606?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:01","pubTimestamp":1765486860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nPLX2A4C6E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KMTS","BK4082"],"gpt_icon":0},{"id":"2590549985","title":"Press Release: Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2590549985","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590549985?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:01","pubTimestamp":1765486860,"startTime":"0","endTime":"0","summary":"KIRKLAND, Wash., Dec. 11, 2025  -- Kestra Medical Technologies, Ltd. , a wearable medical device and digital healthcare company, today reported financial results for the second quarter fiscal 2026, which ended October 31, 2025.-- Generated revenue of $22.6 million in Q2 FY26, an increase of 53%. -- Increased FY26 revenue guidance to $91 million, which would represent. \"Kestra delivered another strong quarter of financial performance, generating revenue growth of 53% while expanding gross margin to over 50%, an important milestone for the company,\" said Brian Webster, President and CEO. \"We also continued to make progress on several key operational objectives, including growing the commercial organization, announcing compelling primary results from our post-approval study at the American Heart Association annual meeting, and fortifying our balance sheet with an equity offering earlier this month. As we progress on our journey to category leadership, our team remains focused on growing t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4232","KMTS","R","BK4022"],"gpt_icon":0},{"id":"2590759794","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2590759794","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590759794?lang=en_us&edition=fundamental","pubTime":"2025-12-11 19:00","pubTimestamp":1765450800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Costco Wholesale Corp.                            1Q    4.27   4:15 PM. ·Kestra Medical Tech Ltd.                          2Q    (.59)  4:01 PM. ·lululemon athletica inc.                          3Q    2.21   4:05 PM. ·Mitek Syss Inc.                                   4Q     .18   4:05 PM. ·Netskope Inc. Class A                             3Q    (.25)      AMC. ·Quanex Building Products Corp.                      4Q     .52       AMC. ·Navan Inc. Class A                     -0.080000  After Market. ·Lennar Corp. Class B                   2.210000  After Market. ·Enerpac Tool Grp Corp Class A                     1Q     .38       AMC. ·General Mills Inc.                                 2Q    1.02   7:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","IE00BK4W5M84.HKD","KMTS","LU0080751232.USD","IE00BGHQF631.EUR","TTC","EDSA","NAVN","LU2360106780.USD","LU2756315318.SGD","SCS","LU2471134952.CNY","OGI","LEN","LU0466842654.USD","MITK","IE00BKPKM429.USD","BK4152","CIEN","JBL","AMCDD","LU2461242641.AUD","LU0661504455.SGD","LEN/WD","RH","LU0353189680.USD","LU2602419157.SGD","MLKN","AVGO","EPAC","LU1934455194.USD","ABM","NTSK","IE00B7SZLL34.SGD","LOVE","GIS","LU2471134879.HKD","LULU","AMC","NX","LU0061474960.USD","COST","LU1868837300.USD","LU2237438978.USD","LU0965509283.SGD","LU2210149790.SGD","MU","WOR","IE00B3PB1722.GBP","LEN.B"],"gpt_icon":1},{"id":"2589334669","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2589334669","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589334669?lang=en_us&edition=fundamental","pubTime":"2025-12-08 19:00","pubTimestamp":1765191600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Braze Inc. Class A                              3Q       .06       AMC. ·Casey's Gen Strs                                2Q      5.19   4:30 PM. ·Core & Main Inc.                                 3Q       .73       BMO. ·Dave & Buster's Ent                             3Q       4:05 PM. ·G-III Apparel Gp.                               3Q      1.61   7:00 AM. ·Ollie's Bargain Outlet                          3Q       .73   7:30 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CASY","JILL","NDSN","COST","XZO","CMP","MAMA","CBRL","OLLI","CPB","GIII","PLAB","OXM","ADBE","SAIL","LE","CIEN","MITK","ASO","KFY","OOMA","FERG","BLLN","NX","ISSC","AMC","REVG","LOVE","LULU","ORCL","TOL","CNM","MTN","CAL","CGNT","EDSA","CHWY","AVAV","BRZE","KMTS","NTSK","ELVA","PLAY","PHR","PL","MOMO","AZO","LAKE"],"gpt_icon":1},{"id":"2588300469","title":"Kestra Medical Technologies (KMTS): Assessing a 20x Sales Valuation After a Recent Double-Digit Daily Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2588300469","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588300469?lang=en_us&edition=fundamental","pubTime":"2025-12-04 15:22","pubTimestamp":1764832967,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies (KMTS) has quietly delivered a sharp move, jumping about 12% in the latest session even as the stock remains down over the past month but up strongly over the past three months.\nSee our latest analysis for Kestra Medical Technologies.\nThat mix of a 12.21% one-day share price return and a softer 7-day share price return of minus 4.37 percent sits alongside a still impressive 51.88 percent 90-day share price return. This suggests medium-term momentum is building from...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-assessing-a-20x-sales-valua","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-assessing-a-20x-sales-valua","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","KMTS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kestramedical.com","stockEarnings":[{"period":"1week","weight":0.0753},{"period":"1month","weight":-0.1031},{"period":"3month","weight":-0.0496},{"period":"6month","weight":0.4931},{"period":"1year","weight":0.4535},{"period":"ytd","weight":-0.0683}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0173},{"period":"6month","weight":0.0814},{"period":"1year","weight":0.1361},{"period":"ytd","weight":0.0104}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Kestra Medical Technologies Inc","nameEN":"Kestra Medical Technologies Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kestra Medical Technologies Inc(KMTS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kestra Medical Technologies Inc(KMTS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kestra Medical Technologies Inc,KMTS,Kestra Medical Technologies Inc股票,Kestra Medical Technologies Inc股票老虎,Kestra Medical Technologies Inc股票老虎国际,Kestra Medical Technologies Inc行情,Kestra Medical Technologies Inc股票行情,Kestra Medical Technologies Inc股价,Kestra Medical Technologies Inc股市,Kestra Medical Technologies Inc股票价格,Kestra Medical Technologies Inc股票交易,Kestra Medical Technologies Inc股票购买,Kestra Medical Technologies Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kestra Medical Technologies Inc(KMTS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kestra Medical Technologies Inc(KMTS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction